Back
Arcus Biosciences Vs. Syndax Pharmaceuticals Industry Stock Comparison
Sell
46
RCUS
Arcus Biosciences
Last Price:
15.78
Seasonality Move:
10.12%
Sell
38
SNDX
Syndax Pharmaceuticals
Last Price:
21.36
Seasonality Move:
8.62%
Sell
46
Arcus Biosciences (RCUS)
is a Sell
Is Arcus Biosciences a Buy, Sell or Hold?
- The current Arcus Biosciences [RCUS] share price is $15.29. The Score for RCUS is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- RCUS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Syndax Pharmaceuticals (SNDX)
is a Sell
Is Syndax Pharmaceuticals a Buy, Sell or Hold?
- The current Syndax Pharmaceuticals [SNDX] share price is $19.69. The Score for SNDX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- SNDX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RCUS Stock Price Chart
What is Arcus Biosciences's stock price today?
-
The Arcus Biosciences share price today is $15.29
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCUS is experiencing slight buying pressure.
SNDX Stock Price Chart
What is Syndax Pharmaceuticals's stock price today?
-
The Syndax Pharmaceuticals share price today is $19.69
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SNDX is experiencing buying pressure, which is a positive indicator for future bullish movement.
RCUS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.31 | Sell |
Relative Strength Index (14 RSI): | 39.3 | Sell |
Chaikin Money Flow: | 55465 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.72 - 17.8) | Sell |
Bollinger Bands (100): | (14.87 - 17.23) | Sell |
SNDX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 57.1 | Buy |
Chaikin Money Flow: | 1326775 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.56 - 19.6) | Buy |
Bollinger Bands (100): | (18.47 - 21.89) | Sell |
RCUS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.88 | Sell |
20-day SMA: | 16.94 | Sell |
50-day SMA: | 16.64 | Sell |
200-day SMA: | 16.34 | Sell |
8-day EMA: | 15.89 | Sell |
20-day EMA: | 16.4 | Sell |
50-day EMA: | 16.46 | Sell |
200-day EMA: | 16.59 | Sell |
SNDX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.05 | Buy |
20-day SMA: | 19.09 | Buy |
50-day SMA: | 19.07 | Buy |
200-day SMA: | 20.97 | Sell |
8-day EMA: | 19.14 | Buy |
20-day EMA: | 19.08 | Buy |
50-day EMA: | 19.31 | Buy |
200-day EMA: | 20.12 | Sell |
Arcus Biosciences Earnings Growth & RCUS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.36 per share.
Syndax Pharmaceuticals Earnings Growth & SNDX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.65 per share, and an increase next year of $0.55 per share.
Arcus Biosciences Technical Analysis
Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Syndax Pharmaceuticals Technical Analysis
Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |